跳至主要内容
临床试验/JPRN-UMIN000048475
JPRN-UMIN000048475已完成未知

Safety and Efficacy of Cerebral Aneurysm Embolization Devices -Observational Study- - Safety and Efficacy of Cerebral Aneurysm Embolization Devices -Observational Study

Kaneka Corporation0 个研究点目标入组 130 人开始时间: 2022年7月26日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with significant stenosis (>50%) in the parent extracranial or intracranial artery proximal to the target aneurysm 2) Patients with target aneurysm in the anterior circulation of the proximal portion of the subxiphoid artery 3) Patients who need to leave the neck to maintain blood flow in the bifurcation or branch in the treatment of a target aneurysm 4) Patients undergoing coiling or stenting of non-target lesions within 30 days prior to treatment of the target lesion 5) Patients with multiple aneurysms and treatment of other aneurysms within 30 days of treatment of the target aneurysm under investigation 6) Patients undergoing flow diverter implantation for treatment of target aneurysm to be studied 7) Patients with a Hunt and Hess score of 3 or higher or a modified Rankin Scale (mRS) score of 4 or higher 8) Patients with contraindications to CT or MRI 9) Patients with contraindications to angiography

研究者

相似试验